Literature DB >> 27397073

RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats.

Caixia Liang1, Yunzhi Xu1, Deyu Zheng1, Xiaohong Sun1, Qunyuan Xu1, Deyi Duan1.   

Abstract

Major histocompatibility complex class l (MHC I) molecules play a role in determining whether transplanted cells will be accepted or rejected, and masking of MHC I on donor cells has been found useful for immunoprotection of neural xenografts. In the present study, primary human embryonic lung fibroblasts (HELF), HELF treated with lentivirus-mediated small interfering RNAs (siRNAs) targeting human leukocyte antigen A2 (HLA A2, MHC I in humans) (siHELF), and rat embryonic lung fibroblasts (RELF) were stereotaxically grafted into the striatum of 6-hydroxydopamine lesioned rats to explore whether knockdown of HLA A2 could reduce host immune responses against xenografts. Before lentiviral infection, the cells were transduced with retroviruses harboring tyrosine hydroxylase cDNA. Knockdown of HLA A2 protein was examined by Western blotting. The immune responses (the number of CD4 and CD8 T-cells in the brain and peripheral blood), glial reaction, and survival of human fibroblasts were quantitatively evaluated by flow cytometry and immunohistochemistry at 4d, 2w, and 6w post-graft. Animal behaviors were assessed by counting apomorphine-induced rotations pre- and post-grafts. It was shown that a lower level of HLA A2 was observed in siHELF grafts than in HELF grafts, and knockdown of HLA A2 decreased rat immune responses, as indicated by less remarkable increases in the number of CD8 and CD4 T-cells in the brain and the ratio of CD4:CD8 T-cells in the peripheral blood in rats grafted with siHELF. Rats grafted with siHELF exhibited a significant improvement in motor asymmetry post-transplantation and a better survival of human fibroblasts at 2w. The increasing number of activated microglia and the decreasing number of astrocytes were found in three groups of rats post-implantation. These data suggested that RNAi-mediated knockdown of HLA A2 could suppress acute rejection against xenogeneic human cell transplants in the rat brain.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Graft rejection; HLA A2; Parkinson's disease; RNA interfering; Xenotransplantation

Mesh:

Substances:

Year:  2016        PMID: 27397073     DOI: 10.1016/j.jneuroim.2016.05.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats.

Authors:  Zhijuan Mao; Chanchan Liu; Suqiong Ji; Qingmei Yang; Hongxiang Ye; Haiyan Han; Zheng Xue
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

2.  Cell-assembled extracellular matrix (CAM) sheet production: Translation from using human to large animal cells.

Authors:  Yoann Torres; Maude Gluais; Nicolas Da Silva; Sylvie Rey; Agathe Grémare; Laure Magnan; Fabien Kawecki; Nicolas L'Heureux
Journal:  J Tissue Eng       Date:  2021-02-12       Impact factor: 7.813

3.  Neuroprotective Effects of Betulin in Pharmacological and Transgenic Caenorhabditis elegans Models of Parkinson's Disease.

Authors:  Chia-Wen Tsai; Rong-Tzong Tsai; Shih-Ping Liu; Chang-Shi Chen; Min-Chen Tsai; Shao-Hsuan Chien; Huey-Shan Hung; Shinn-Zong Lin; Woei-Cherng Shyu; Ru-Huei Fu
Journal:  Cell Transplant       Date:  2017-12       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.